Affymax Continues Rising

Shares of Affymax Inc. (Nasdaq: AFFY) continued rising by soaring 37 cents to close at $1.81 after a Seeking Alpha contributor expressed confidence that the biopharmaceutical would successfully address safety concerns of its anemia drug Omontys.



Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here